Are you aware that ticks can spread more than Lyme? Sadly, they also possess the power to transmit a number of co-infections, one being babesiosis. This week's guest, Dr. Geoffrey Dow, is no stranger to understanding the wrath of this infection. He studies it extensively alongside malaria and dengue fever. After his daughter struggled with Lyme and tick-borne illnesses, Dr. Dow was compelled to co-found 60 Degrees Pharmaceuticals. His company has developed a drug to combat babesia called Arakoda, which kills all lifecycle stages of the parasite, similar to malaria treatment, and targets persistent forms to prevent relapse.

Take a listen as Dr. Dow discusses the challenges in diagnosing babesiosis, noting that while acute cases can be detected through blood smears, standard PCR tests become ineffective soon after symptoms subside. Dr. Dow estimates that there are up to 900,000 cases of babesiosis a year, making better testing and treatment imperative.

Dr. Dow will also be needing participants for 60 Degrees chronic babesiosis study once it opens for enrollment so keep your eyes peeled for this to happen soon if you are interested in helping.